ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 17.7744 ↑ 0.6%
[as on 3 November, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 40 SMA
  • 500 SMA

Returns

CAGR returns till date

CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option and its peers as on 3 November, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 13.63% 0.6% 3.29% 0.83% -1.41% 7.78% 17.98%---
SBI MNC FUND - REGULAR PLAN -GROWTH 10.97% 0.76% 2.91% -1.37% -4.37% 9.5% 6.24% 6.5% 11.65% 10.32%
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 21.07% 0.61% 3.01% 1.04% -0.98% 16.5% 23.22% 17.89% 23.4% 13.78%
SBI COMMA Fund - REGULAR PLAN - Growth 0.8% 0.52% 2.72% -0.7% -4.78% 1.88% 14.13% 9.06% 16.65% 13.73%
SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth -5.29% 1.31% 3.83% 3.85% -5.01% -4.45% 8.98% 6.45% 11.2% 11.03%
SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH -1.4% 0.59% 3.73% 2.11% -5.38% -2.2% 11.18% 14.06% 17.54% 14.3%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns------ -8.89% 32.42% 41.76% -10.78%

Discrete returns (monthly)

MonthJan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026Oct 2026
Returns -6.96% 6.8% -4.76% 7.57% 2.95% 5.81% 3.87% 2.74% -2.96% 0.23%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 2.43%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.27% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.73%

Equity

NameSymbol / ISINSectorWeight %Other links
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology12.58%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology9.23%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.72%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services4.84%
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.75%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology4.31%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology4.22%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology4.02%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.97%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology3.31%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology3.18%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology3.10%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services2.98%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.92%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services2.82%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology2.43%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology1.97%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.92%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.59%
Shilpa Medicare LimitedSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.59%
Healthcare Global Enterprises LimitedHCG (INE075I01017)Healthcare Services1.55%
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies1.50%
Aster DM Quality Care LimitedASTERDM (INE914M01019)Healthcare Services1.47%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.32%
Shaily Engineering Plastics LimitedSHAILY (INE151G01028)Consumer Durables1.25%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology1.25%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology1.15%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services1.05%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology1.02%
Linde India LimitedLINDEINDIA (INE473A01011)Chemicals & Petrochemicals0.99%
Rainbow Childrens Medicare LimitedRAINBOW (INE961O01016)Healthcare Services0.93%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.87%
Supriya Lifescience LimitedSUPRIYA (INE07RO01027)Pharmaceuticals & Biotechnology0.81%
Metropolis Healthcare LimitedMETROPOLIS (INE112L01020)Healthcare Services0.74%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology0.71%
Caplin Point Laboratories LimitedCAPLIPOINT (INE475E01026)Pharmaceuticals & Biotechnology0.61%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.60%

Debt

NameIsinRatingWeight %Yield
Portfolio data is as on date 31 August, 2026

NAV history

ITI Pharma and Healthcare Fund - Regular Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
3 November, 202617.7744 0.6%
2 November, 202617.6687 0.17%
30 October, 202617.6386 0.9%
29 October, 202617.4810 0.35%
28 October, 202617.4192 1.22%
27 October, 202617.2087 2%
26 October, 202616.8716 1.7%
23 October, 202616.5901 -0.94%
22 October, 202616.7481 -0.09%
21 October, 202616.7632 -0.55%
19 October, 202616.8555 -1.04%
16 October, 202617.0335 -0.24%
15 October, 202617.0737 0.16%
14 October, 202617.0471 -1.01%
13 October, 202617.2218 -0.3%
12 October, 202617.2731 -0.01%
9 October, 202617.2751 0.65%
8 October, 202617.1643 -2.36%
7 October, 202617.5796 -0.36%
6 October, 202617.6429 1.11%
5 October, 202617.4492 -1.01%
1 October, 202617.6281 -0.2%
30 September, 202617.6626 -2.31%
29 September, 202618.0807 0.17%
28 September, 202618.0503 -1.07%
25 September, 202618.2447 -0.36%
24 September, 202618.3102 -0.73%
23 September, 202618.4454 0.83%
22 September, 202618.2936 -0.58%
21 September, 202618.4005

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is 17.7744 as on 3 November, 2026.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 13.63% as on 3 November, 2026.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 7.78% as on 3 November, 2026.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 17.98% as on 3 November, 2026.
  • What are top 10 holdings of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    Top 10 holdings of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are:
    • Sun Pharmaceutical Industries Limited
    • Divi's Laboratories Limited
    • Apollo Hospitals Enterprise Limited
    • Max Healthcare Institute Limited
    • Torrent Pharmaceuticals Limited
    • Dr. Reddy's Laboratories Limited
    • Cipla Limited
    • Laurus Labs Limited
    • Aurobindo Pharma Limited
    • Mankind Pharma Limited
    • Neuland Laboratories Limited
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
    ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.